- Home
- RPRX vs CNC Comparison
RPRX vs CNC Comparison
Compare RPRX & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPRX
- CNC
- Stock Information
- Founded
- RPRX 1996
- CNC 1984
- Country
- RPRX United States
- CNC United States
- Employees
- RPRX N/A
- CNC N/A
- Industry
- RPRX Biotechnology: Pharmaceutical Preparations
- CNC Medical Specialities
- Sector
- RPRX Health Care
- CNC Health Care
- Exchange
- RPRX Nasdaq
- CNC Nasdaq
- Market Cap
- RPRX 15.6B
- CNC 14.4B
- IPO Year
- RPRX 2020
- CNC 2001
- Fundamental
- Price
- RPRX $35.87
- CNC $29.04
- Analyst Decision
- RPRX Strong Buy
- CNC Hold
- Analyst Count
- RPRX 3
- CNC 16
- Target Price
- RPRX $45.33
- CNC $42.20
- AVG Volume (30 Days)
- RPRX 3.1M
- CNC 13.1M
- Earning Date
- RPRX 08-06-2025
- CNC 10-24-2025
- Dividend Yield
- RPRX 2.45%
- CNC N/A
- EPS Growth
- RPRX 54.86
- CNC N/A
- EPS
- RPRX 2.32
- CNC 4.07
- Revenue
- RPRX $2,305,243,000.00
- CNC $159,560,000,000.00
- Revenue This Year
- RPRX $33.77
- CNC $30.26
- Revenue Next Year
- RPRX $4.62
- CNC N/A
- P/E Ratio
- RPRX $15.45
- CNC $7.14
- Revenue Growth
- RPRX 3.02
- CNC 10.57
- 52 Week Low
- RPRX $24.05
- CNC $25.08
- 52 Week High
- RPRX $38.00
- CNC $80.59
- Technical
- Relative Strength Index (RSI)
- RPRX 42.45
- CNC 47.94
- Support Level
- RPRX $35.48
- CNC $28.24
- Resistance Level
- RPRX $36.99
- CNC $29.27
- Average True Range (ATR)
- RPRX 0.68
- CNC 0.77
- MACD
- RPRX -0.14
- CNC 0.64
- Stochastic Oscillator
- RPRX 7.28
- CNC 76.79
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About CNC Centene Corporation
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.